We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Myelodysplastic Syndrome Diagnosed With Peripheral Blood Samples

By LabMedica International staff writers
Posted on 14 Nov 2022

Myelodysplastic syndromes (MDS) encompass a heterogeneous group of clonal bone marrow neoplasms, with a median age at diagnosis of 70 years. More...

MDS are characterized by recurrent cytogenetic and molecular abnormalities, morphologic dysplasia for one or more hematopoietic cell lineage and ineffective hematopoiesis.

Cytomorphological evaluation of bone marrow is the reference standard for the diagnosis of MDS and may be complemented by information obtained from conventional cytogenetic, flow cytometry and molecular profiling analysis. Peripheral blood neutrophil myeloperoxidase expression quantified by flow cytometric analysis has the potential to rule out MDS without requiring invasive bone marrow aspiration.

A large team of hematopathologists at the Grenoble Alpes University Hospital (Grenoble, France) and their colleagues are evaluating a cross-sectional diagnostic accuracy study of two index tests by comparison with a reference standard in consecutive unselected adult patients conducted at a single university hospital. The team evaluated a hypothesis that a flow cytometry-based method involving a single-use tube containing lyophilized reagents will provide the accuracy needed to reject a diagnosis of MDS by analysis of peripheral blood neutrophil myeloperoxidase expression, in addition to other hypotheses.

The study examined an approach involving a product called Lyotube Stain 468 (BD Biosciences, San Jose, CA, USA), compared with an approach using a laboratory-developed liquid reagent-based test, in evaluating possible MDS. The Lyotube Stain 468 product includes dried reagents associated with five fluorochromes, while the laboratory-developed test uses liquid reagents associated with the same fluorochromes. With both approaches, an anti-myeloperoxidase antibody is applied to samples, and myeloperoxidase expression from peripheral blood neutrophils is measured. The team used a BD Biosciences three-laser, eight-color BD FACSCanto-II flow cytometer. The primary outcome is the reference diagnosis of MDS or CMML established by bone marrow examination by two independent experienced hematopathologists blinded to the index test results.

The investigators identified the strengths of this study to include the use of an adequate reference approach to MDS diagnosis, limited spectrum bias owing to enrollment of unselected consecutive patients, and a prespecified threshold for evaluation of diagnostic accuracy. Limitations of the study that they identified include the single-center nature of the study setting, in addition to conventional cytogenetic and molecular profiling approaches not being available to all patients in the study. The study was published in the November 2022 issue of the journal BMJ Open.

Related Links:
Grenoble Alpes University Hospital
BD Biosciences


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Specimen Radiography System
TrueView 200 Pro
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.